Canon’s Deep Learning Spectral CT gets FDA Nod for Expanded Cardiovascular Applications

By News Release

Canon Medical Systems USA, Inc. announced that its Deep Learning Spectral CT has received US FDA 510(k) clearance for expanded capabilities into cardiovascular applications on the company’s Aquilion ONE/PRISM Edition CT system. Clinicians can now acquire whole-heart spectral images in one beat thanks to the system’s 16 cm wide area detector, 0.275 second whole-heart acquisition with rapid kVp switching and Deep Learning Spectral Reconstruction.

The Aquilion ONE / PRISM Edition integrates artificial intelligence (AI) technology to maximize conventional and spectral CT capabilities while providing deep clinical insights to assist physicians in making more informed decisions across the patient’s care cycle. To make it even easier for clinicians, the fully integrated end-to-end workflow is easy to use and can be incorporated into routine protocols.

“By integrating AI into spectral imaging, Canon Medical is bringing innovative technology to the market that can make an immediate impact for clinicians, empowering them to make definitive diagnoses,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “With Deep Learning Spectral CT, we have leveraged the power of AI to overcome several of the barriers that are otherwise associated with dual energy and spectral imaging.”

Back To Top

Canon’s Deep Learning Spectral CT gets FDA Nod for Expanded Cardiovascular Applications.  Appl Radiol. 

By News Release| April 20, 2021

About the Author

News Release

News Release

Copyright © Anderson Publishing 2021